Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass

被引：14

作者：

Ural, Kelly ^{[1
]}

Owen, Christopher ^{[1
]}

机构：

[1] Ochsner Clin Fdn, Dept Anesthesiol, 1514 Jefferson Hwy, New Orleans, LA 70121 USA

来源：

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2016年 / 30卷 / 06期

关键词：

Hepcon; ACT; cardiopulmonary bypass; heparin; protamine; BLOOD-LOSS; COAGULATION; TRANSFUSION; MANAGEMENT; IMPACT;

D O I：

10.1053/j.jvca.2016.07.001

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：1727 / 1729

页数：3

共 15 条

[1] Hemostasis management by use of Hepcon/HMS™:: Increased bleeding without increased need for blood transfusion [J].

Beholz, S ;

Grubitzsch, H ;

Bergmann, B ;

Wollert, HG ;

Eckel, L .

THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (05) :322-327

[2]

Chan AKC, 1997, THROMB HAEMOSTASIS, V77, P270

[3] COMPARISON OF ACTIVATED COAGULATION LIME AND WHOLE-BLOOD HEPARIN MEASUREMENTS WITH LABORATORY PLASMA ANTI-XA HEPARIN CONCENTRATION IN PATIENTS HAVING CARDIAC OPERATIONS [J].

DESPOTIS, GJ ;

SUMMERFIELD, AL ;

JOIST, JH ;

GOODNOUGH, LT ;

SANTORO, SA ;

SPITZNAGEL, E ;

COX, JL ;

LAPPAS, DG .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (06) :1076-1082

[4]

Despotis GJ, 1996, THROMB HAEMOSTASIS, V76, P902

[5] Anticoagulation monitoring during cardiac surgery - A review of current and emerging techniques [J].

Despotis, GJ ;

Gravlee, G ;

Filos, K ;

Levy, J .

ANESTHESIOLOGY, 1999, 91 (04) :1122-1151

[6] Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients [J].

Despotis, GJ ;

Filos, KS ;

Zoys, TN ;

Hogue, CW ;

Spitznagel, E ;

Lappas, DG .

ANESTHESIA AND ANALGESIA, 1996, 82 (01) :13-21

[7] THE IMPACT OF HEPARIN CONCENTRATION AND ACTIVATED CLOTTING TIME MONITORING ON BLOOD CONSERVATION - A PROSPECTIVE, RANDOMIZED EVALUATION IN PATIENTS UNDERGOING CARDIAC OPERATION [J].

DESPOTIS, GJ ;

JOIST, JH ;

HOGUE, CW ;

ALSOUFIEV, A ;

KATER, K ;

GOODNOUGH, LT ;

SANTORO, SA ;

SPITZNAGEL, E ;

ROSENBLUM, M ;

LAPPAS, DG .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :46-54

[8]

Hashimoto K, 1999, J CARDIOVASC SURG, V40, P645

[9] Hemostatic activation and inflammatory response during cardiopulmonary bypass - Impact of heparin management [J].

Koster, A ;

Fischer, T ;

Praus, M ;

Haberzettl, H ;

Kuebler, WM ;

Hetzer, R ;

Kuppe, H .

ANESTHESIOLOGY, 2002, 97 (04) :837-841

[10] The activated coagulation Time: Suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery [J].

Martindale, SJ ;

Shayevitz, JR ;

DErrico, C .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (04) :458-463

← 1 2 →